Fan Xu

Dr. Fan Xu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2023 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
PDF file
FXFan Xu
Fan Xu
LXLinfeng Xie
Linfeng Xie
JHJian He
Jian He
QWQingsong Wu
Qingsong Wu
XLXinfan Lin
Xinfan Lin
LCLiangwan Chen
Liangwan Chen
Objective. Predicting risk factors for acute kidney injury (AKI) after total arch replacement via modified triple-branched stent graft (MTBSG) implantation in patients with acute type A aortic dissection (AAAD) by conducting a nomogram. Methods. We collected the clinical data of 254 patients with AAAD who underwent MTBSG implantation surgery in our center. The independent risk factors of postoperative AKI were screened by univariate and multivariate logistic regression analysis and combined into a nomogram. We use receiver operating characteristic (ROC) curves, decision curve analysis (DCA), clinical impact curve (CIC), and calibration plots to evaluate the accuracy of the nomogram model. Results. Multiple logistic regression analysis showed that the risk factors of AKI after MTBSG implantation were age, malperfusion syndrome, preoperative serum creatinine, cardiopulmonary bypass time, and amount of red blood cell (RBC) transfusion. Based on these five risk factors, we established a nomogram model. The good accuracy and clinical applicability of the model were verified by drawing ROC curve (area under the curve (AUC)=0.854), DCA curve, CIC curve, and calibration curve. Conclusions. Using perioperative clinical data to establish a nomogram model of AKI in patients with AAAD who received MTBSG implantation can be used as a tool to predict the occurrence of AKI after operation.

20 February 2023 in JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
Verified
Journal Article
Closed access
YHYun-Nan Hu
Yun-Nan Hu
XLXiao-Chai Lv
Xiao-Chai Lv
XCXiao-Dong Chen
Xiao-Dong Chen
XCXing-Feng Chen
Xing-Feng Chen
LCLiangwan Chen
Liangwan Chen
FXFan Xu
Fan Xu
Objective: Interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) promote aortic dissection (AD). However, the mechanisms involved remain unclear. This study evaluated IL-1β and TNF-α effect on mitogen-activated protein kinase (MAPK) signaling and matrix metalloproteinase 9 (MMP-9) expression in dissected rat aorta receiving mechanical stretch. Methods: Rats were administered with β-aminopropionitrile to produce an AD model. Dissected aortas were mechanically stretched (3 g) and incubated with TNF-α, IL-1β, and inhibitors of the c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (p38), and extracellular signal-regulated kinase 1/2 (ERK1/2) pathways (SB203580, U0126, and SP600125, respectively). IL-1β, TNF-α, ERK1/2, phospho-p38 (p-p38), p38, p-ERK1/2, JNK1, p-JNK1, and MMP-9 levels were assessed by immunohistochemical analysis and/or quantitative real-time polymerase chain reaction (qRT-PCR). Results: IL-1β, TNF-α, p-ERK1/2, p-p38, p-JNK1, and MMP-9 levels increased in the 3 g group relative to the 0 g group (p < 0.05) and were up-regulated by exogenous IL-1β and TNF-α in both the 0 and 3 g groups (p < 0.05). Treatment with p38/ERK1/2/JNK inhibitors remarkably down-regulated IL-1β, TNF-α, p-ERK1/2, p-p38, p-JNK1, and MMP-9 in the 3 g + IL-1β and 3 g + TNF-α groups (p < 0.05). IL-1β, TNF-α, p-ERK1/2, p-p38, p-JNK1, and MMP-9 levels were significantly lower in the 3 g + SB203580/SP600125/U0126 + IL-1β and 3 g + SB203580/SP600125/U0126 + TNF-α groups than the 3 g group (p < 0.05). Conclusions: Our data demonstrated that MMP-9 was up-regulated by IL-1β and TNF-α through ERK1/2/p38/JNK signaling in dissected rat aorta.

21 August 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
LXLinfeng Xie
Linfeng Xie
GZGuican Zhang
Guican Zhang
JHJian He
Jian He
YSYanming Shen
Yanming Shen
DLDongshan Liao
Dongshan Liao
FXFan Xu
Fan Xu
Background: In children with perimembranous ventricular septal defect, surgical repair requires sternotomy and leaves unsightly scars, which can trigger long-term physical and psychological distress. However, transcatheter device closure is limited by vascular diameter, radiographic exposure, and expensive DSA equipment. We used an ultra-small left intercostal incision for transthoracic device closure to avoid the above problems and investigated its safety and feasibility by comparing it with surgical repair.Methods: This study enrolled 358 children with perimembranous ventricular septal defect. Among them, 152 patients were treated by surgical closure and 206 by transthoracic device closure via an ultra-small left intercostal incision. Perioperative clinical data and postoperative follow-up results were collected and analyzed retrospectively.Results: The success rate was similar (P = 0.265) in the two groups: 203/206 patients in the device group vs. 152/152 patients in the surgical group. The operative time, intensive care unit time, mechanical ventilation time, and postoperative hospital stay were significantly shorter in the device group than in the surgical group. Although the incision length of the device group (1.1 ± 0.2 cm) was significant shorter (P < 0.001) than that of the surgical group (6.7 ± 1.5 cm), there was no difference in hospitalization costs between the two groups (P = 0.099). Except for small residual shunt (16/206 vs. 3/152, P = 0.017), the incidence of complications in the device group was lower or equal to that in the surgical group, and all small residual shunt disappeared during follow-up. There was no thoracic deformity in the device group, compared with 11 cases in the surgery group during follow-up (P < 0.001).Conclusions: Transthoracic device closure via an ultra-small left intercostal incision under transesophageal echocardiography guidance is safe and feasible. With appropriate indications, it can be a suitable alternative to surgical closure for treating perimembranous ventricular septal defect in children.